首页/数据集/Intervention characteristics of included trials of incretin treatment in patients with type 2 diabetes mellitus.

Intervention characteristics of included trials of incretin treatment in patients with type 2 diabetes mellitus.

Figshare2016-09-28 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Intervention_characteristics_of_included_trials_of_incretin_treatment_in_patients_with_type_2_diabetes_mellitus_/3948282 数据链接链接失效反馈

官方服务：

资源简介：

Intervention characteristics of included trials of incretin treatment in patients with type 2 diabetes mellitus.

应用场景：

创建时间：

2016-09-28

糖尿病药物试验

GLP-1激动剂疗效评估

The purpose of this study is to assess the efficacy and safety of once-weekly dulaglutide compared to placebo in participants with type 2 diabetes who have inadequate glycemic control with sulfonylure

DataCite Commons2024-12-02 更新20

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 50 mg Compared With Placebo as an Add-on to Glimepiride in Subjects With Type 2 Diabetes

糖尿病药物试验

血糖控制效果

The purpose of this study is to evaluate the effect of TAK-875 compared to placebo on glycemic control over a 24-week Treatment Period when used as an add-on to glimepiride in addition to diet and exe

DataCite Commons2024-12-02 更新10

L-Tryptophan as a Frontier in Diabetes Management: A Pilot Study

糖尿病药物试验

L-色氨酸疗效评估

Hyperglycemia is associated with malfunctioning of beta cells of pancreas and has been linked with the mortality of the pancreatic cells. The present study aims to evaluate the hypoglycemic action of

Figshare2025-08-13 更新10

Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics

心脏电生理药物筛选

糖尿病药物试验

Identification of drug induced electrical instability of the heart curtails development, and introduction, of potentially proarrhythmic drugs. This problem usually requires complimentary contact based

NIAID Data Ecosystem20

Dataset from A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of the Combination of SYR-322 (SYR110322) and Pioglitazone HCl (ACTOS®), in Subjects With Type 2 Diabetes

糖尿病药物试验

药物疗效评估

The purpose of this study is to evaluate the safety and efficacy of alogliptin, once daily (QD), taken in combination with pioglitazone in adults with type 2 diabetes mellitus.

NIAID Data Ecosystem10

Intervention characteristics of included trials of incretin treatment in patients with type 2 diabetes mellitus.

资源简介：

相关数据集